We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

4.9.1: Dopaminergic drugs used in parkinsonism

Part of chapter 4 Central Nervous System, section 4.9 Drugs used in parkinsonism and related disorders

High-level prescribing trends for Dopaminergic drugs used in parkinsonism (BNF section 4.9.1) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by CCG, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? We can often provide one-off custom extracts from our prescribing data for free. to find out more.


Amantadine Hydrochloride (0409010B0)
Apomorphine Hydrochloride (0409010A0)
Apomorphine Hydrochloride Hemihydrate (0409010AC)
Cabergoline (0409010U0)
Carbidopa (0409010D0)
Co-Beneldopa (Benserazide/Levodopa) (0409010K0)
Co-Careldopa (Carbidopa/Levodopa) (0409010N0)
Entacapone (0409010V0)
Levodopa (0409010I0)
Levodopa/Carbidopa/Entacapone (0409010X0)
Memantine Hydrochloride (0409010M0)
Opicapone (0409010AB)
Pergolide Mesilate (0409010P0)
Pramipexole (0409010W0)
Rasagiline Mesilate (0409010Y0)
Ropinirole Hydrochloride (0409010H0)
Rotigotine (0409010Z0)
Safinamide (0409010AA)
Selegiline Hydrochloride (0409010T0)
Tolcapone (0409010S0)